The name change is just one announcement from the changing company.
EPAX AS (Aalesund, Norway) has been renamed Epax Norway AS, the company announced last week. The global supplier of omega-3 docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) oils has seen several changes over the last several months, but it insists that its industry commitment will remain the same.
EPAX introduced a new CEO in Terje Bakken this July and now holds a resource center in Hoydebygda, Norway and a recently acquired manufacturing plant in Seals Sands, United Kingdom.
EPAX was acquired by Trygg Pharma, a joint venture of Aker Biomarine (Oslo, Norway) and Lindsay Goldberg (Manhattan, NY) in late 2010.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Continuing innovation in algae-DHA: 2024 Natural Products Expo West Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.